2025-07-22
Post Time: 2025-07-22
Error: No content files found.A new Cleveland Clinic-led study has identified sildenafil - an FDA-approved therapy for erectile dysfunction (Viagra) and pulmonary hypertension (Ravatio) – as a promising drug candidate to help prevent migraine viagra and treat Alzheimer's disease. According to findings published in Nature Aging, the research team, led by Feixiong Cheng, Ph.D., of Cleveland Clinic's Genomic Medicine Institute, used computational methodology to screen and side effects of taking viagra for the first time validate FDA-approved drugs as potential therapies for Alzheimer's disease. Through a large-scale analysis of a database of more than 7 million patients, they determined that sildenafil is associated with 69% reduced incidence of Alzheimer's disease, indicating the need for follow-up clinical trial testing of the drug's efficacy in patients with the disease. For more information, log into: Get the latest medical and heath news at medicaldialogues.in Follow us on Twitter: Facebook: Instagram: LinkedIn: Website: how many males using enhancement pills